Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6122653 | Journal of Infection | 2016 | 10 Pages |
Abstract
ImmunoCAP and Immulite were statistically significantly superior to the other assays. Precipitins testing performed poorly. The currently accepted ImmunoCAP cut-off of 40Â mg/L appears sub-optimal for CPA diagnosis and may require revision in this context.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Iain D. Page, Malcolm D. Richardson, David W. Denning,